Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating Cancer

被引：0
|
作者：
Sabnis, Ram W. [1 ]
机构：
[1] Gambrell & Russell LLP, Smith, Atlanta, GA 30309 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2024年 / 15卷 / 06期
关键词：
D O I：
10.1021/acsmedchemlett.4c00177
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Provided herein are novel 2,7-naphthyridine compounds as MASTL inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.
引用
收藏
页码：748 / 749
页数：2
相关论文
共 50 条
  • [21] Non-linear optical properties of 2,7-naphthyridine derivatives for optical switching applications: a DFT study
    Dhanya, P. K.
    Chandran, R. Prakash
    Nair, Sobha Vijayan
    Pillai, Renjith Raveendran
    NEW JOURNAL OF CHEMISTRY, 2024, 48 (06) : 2689 - 2706
  • [22] Synthesis of new heterocyclic systems fused at pyrazolo[3,4-c]-2,7-naphthyridine core
    Sirakanyan, Samvel N.
    Hakobyan, Elmira K.
    Spinelli, Domenico
    Geronikaki, Athina
    Kartsev, Victor
    Yegoryan, Hasmik A.
    Hovakimyan, Anush A.
    MENDELEEV COMMUNICATIONS, 2022, 32 (03) : 393 - 394
  • [23] Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2023,
  • [24] A novel lumazine synthase inhibitor derived from oxidation of 1,3,6,8-tetrahydroxy-2,7-naphthyridine to a tetraazaperylenehexaone derivative
    Zhang, Yanlei
    Illarionov, Boris
    Bacher, Adelbert
    Fischer, Markus
    Georg, Gunda I.
    Ye, Qi-Zhuang
    Velde, David Vander
    Fanwick, Phillip E.
    Song, Yunlong
    Cushman, Mark
    JOURNAL OF ORGANIC CHEMISTRY, 2007, 72 (08): : 2769 - 2776
  • [25] Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (06): : 775 - 776
  • [26] Elaboration of 1,8-naphthyridine-2,7-dicarboxaldehyde into novel 2,7-dimethylimine derivatives
    Vu, C
    Walker, D
    Wells, J
    Fox, S
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2002, 39 (04) : 829 - 832
  • [27] Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (10): : 1336 - 1337
  • [28] Novel Bicyclic Heterocyclic Compounds as CD73 Inhibitors for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 16 (01): : 10 - 11
  • [29] Novel Indazole Compounds as PKMYT1 Kinase Inhibitors for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (11): : 1810 - 1811
  • [30] Novel Phosphorylpurinone Compounds for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (04): : 441 - 442
12345